2025 Concentrates Consumption Treatment 
Cannabis Law Report
SEPTEMBER 22, 2022
AB 1885 expands the purpose of the comprehensive system established by Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to include the control and regulation of the cultivation, distribution, transport, storage, manufacturing, processing, and sale of cannabis products intended for use on, or consumption by, animals.
Cannabis Law Report
FEBRUARY 18, 2020
The first person to investigate the purported effects of cannabis consumption was Fiorello H. In 1944, the La Guardia Committee report studying the issue of cannabis consumption in New York was released. Researchers predict that the market will be valued at $7 billion by the year 2025. Marijuana legislation main driving forces.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dykema (Cannabis Law Blog)
JUNE 7, 2023
The bill legalizes the production and sale of marijuana flower concentrates, topical and edible products, immature cannabis plants and seeds, and hemp-derived THC products. Cannabis manufacturers : Business may process cannabis flower into other products, such as concentrates, edibles, and topicals.
Cannabis Law Report
JUNE 8, 2021
Currently, the development of effective drugs based on CBD for the treatment of Alzheimer’s disease, dementia, diabetes, and epilepsy is underway. External use allows the production of creams and cosmetics for skin care, balms for muscles and joints treatment, cosmetics for bathing, hair care products.
Cannabis Law Report
OCTOBER 17, 2019
Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. billion in 2025, according to Grandview Research. The new law rolled out first with dried cannabis and low-concentration cannabis oils.
Expert insights. Personalized for you.
52 
Let's personalize your content